GSK’s Witty Makes A Case Against More Business Separations
This article was originally published in The Pink Sheet Daily
Executive Summary
With GSK’s troubled business coming under increased pressure in 2014, investors are anxious for news about how the CEO plans to right the big pharma ship. Witty said the three-pronged business he is building will be on more solid ground after the deal with Novartis closes.